Related Experiment Video
Updated: Feb 21, 2026
09:28
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
Published on: May 18, 2020
9.3K
Progress in biopharmaceutical development
1Department of Bioengineering, Institute of Biotechnology and Antibiotics, Warsaw, Poland.
Biotechnology and Applied Biochemistry
|October 4, 2017
Summary
Biopharmaceutical drugs, including biobetters and biosimilars, are transforming medicine and driving market growth. Their development and regulatory pathways are crucial for future healthcare advancements and cost reduction.
Area of Science:
- Biopharmaceutical drug development and market analysis.
Background:
- Biopharmaceuticals, introduced in 1982, have revolutionized disease treatment across medicine.
- The biopharmaceutical market shows dynamic growth potential due to high demand.
- Biobetters offer enhanced efficacy, while biosimilars aim to reduce treatment costs.
Purpose of the Study:
- To review recent advancements in biopharmaceutical development.
- To discuss regulatory considerations for innovative biopharmaceuticals and biosimilars.
- To analyze the current biopharmaceutical market and future forecasts.
Main Methods:
- Literature review of biopharmaceutical development.
- Analysis of market trends and growth forecasts.
- Examination of regulatory landscapes for biopharmaceuticals and biosimilars.
Main Results:
- Biopharmaceuticals are increasingly vital in modern medicine.
- Biobetters represent a significant advancement in drug efficacy.
- Biosimilars are entering major markets, impacting treatment costs.
- The biopharmaceutical market is experiencing rapid expansion.
Conclusions:
- Continued innovation in biopharmaceuticals, including biobetters and biosimilars, is essential.
- Streamlined regulatory processes are key for market access.
- The growing biopharmaceutical market offers substantial opportunities and challenges.
Related Concept Videos
01:28Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
01:11Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
298
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
298
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
338
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
338
01:26Drug Discovery: Overview
12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
01:26Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K